Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
Patient leaflets and SmPCs, drug interaction checker, official dosages and NHS pharmacy opening hours — all in one place.
The electronic medicines compendium (emc) no longer publishes a Summary of Product Characteristics for this product, which usually means it is no longer marketed in the UK. The patient leaflet below is kept for reference, but the product may not be available.
If you were prescribed this medicine, other products containing Atropine sulfate may still be available. Do not stop your treatment — ask your pharmacist or GP what to use instead.
for Minims® Atropine Sulphate contains a mydriatic and cycloplegic agent. It is used to enlarge the pupil of your eye. Your doctor or eye specialist may use it to examine your eye more closely, or as part of a treatment program. This medicine is indicated for children, adults and the elderly. 2. Before you use your eye drops Do not use these drops if . you are allergic to the active substance (atropine sulphate) or any of the ingredients (refer to the end of this leaflet). . you have history of closed angle glaucoma (with your eyes likely to develop sudden increased internal pressure when the pupil is enlarged). If you are pregnant, may be pregnant, or are breastfeeding Tell your doctor or eye specialist, he/she may decide to use these drops or to prescribe you an alternative. Contact lenses Your doctor will ask you to remove your contact lenses prior to the administration of the drops. Do not wear your contact lenses until the effects of the drops have completely worn off. Driving and using machines As with all eye drops, your vision may be blurred after putting the drops in. Wait until your vision is clear before driving or using machines.
your eye drops The drops are for single use only and provided in single use Minims units, to treat both eyes if necessary. Once opened, use immediately. Discard any unused portion. Dosage The normal dose is one drop in each eye. If necessary, your doctor or eye specialist will tell you to use more than one drop. Method of administration The doctor or eye specialist will normally put the drops in your eye for you, but if you are putting the eye drops in yourself, then follow these instructions carefully: 1. Wash your hands. 2. Use a mirror, this will help you to see what you are doing. 3. Carefully dry your eyes using a tissue, and twist off the cap from the Minims body of the unit. 4. Pull your lower eyelid down gently, and then carefully place 1 drop inside your lower eyelid. 5. Close your eye and blink a few times to make sure your eye is covered by the liquid. 6. Close the eyelids. It is advisable to press gently on the inner corner of your eyelid for 3 minutes. This will help stop the solution draining into your nose and throat. This is especially advisable in children, the elderly and population at risk. 7. Repeat steps 4, 5 and 6 for the other eye if necessary, then throw away the Minims unit, even if some solution remains.
If you use more Minims® Atropine Sulphate than you should, an overdose is very unlikely to occur. If you suddenly feel unwell after receiving the drops, tell your doctor or eye specialist or contact your nearest emergency department immediately.
The following side effects may occur occasionally: the skin around the eyes can be sore. Your eyes can be swollen, red and itchy. This is more likely to happen if the drops are used more than once. dry mouth, flushing of the skin, increased body temperature, constipation, difficulty in passing urine, fast heartbeat. Reporting of side effects If you get any side effects, talk to your doctor or pharmacist. This includes any side effects not listed in this leaflet. You can also report side effects directly via: Yellow Card Scheme at: www.mhra.gov.uk/yellowcard or search for MHRA Yellow Card in the Google Play or Apple App Store.
Malta: www. medicinesauthority.gov.mt/adrportal. By reporting side effects you can help provide more information on the safety of this medicine.
your eye drops Keep out of the sight and reach of children. Do not use the eye drops after the expiry date which is stated on the overwrap of each unit and on the carton after the letters "EXP". The expiry date refers to the last day of that month. Do not store above 25°C. Do not freeze. Store in original package in order to protect from light. The drops are for single use only and provided in single use Minims units, to treat both eyes if necessary. Once opened, use immediately. Discard any unused portion. Medicines should not be disposed of via wastewater or household waste. Ask your pharmacist how to dispose of medicines no longer required. These measures will help to protect the environment. 6. Further information What do your eye drops contain The active ingredient is atropine sulphate. Each Minims unit contains approximately 0.5 ml eye drops solution of atropine sulphate 1% w/v (5 mg). The other ingredients are hydrochloric acid (for pH adjustment) and purified water. This medicine does not contain a preservative as it is a sterile single use unit. Contents of the pack Each carton contains 20 units. Marketing Authorisation Holder: Bausch & Lomb UK Ltd., 106 London Road, Kingston-Upon-Thames Surrey, KT2 6TN, United Kingdom Manufacturer: Laboratoire Chauvin
Zone Industrielle de Ripotier 50 Avenue Jean Monnet 07200 Aubenas France DATE OF PREPARATION: November 2023
Minims Atropine Sulphate 1%, Eye drops solution comes as eye drops. Always follow the dose your doctor or pharmacist has given you, and read the leaflet that comes with the medicine.
The active substance in Minims Atropine Sulphate 1%, Eye drops solution is atropine sulfate.
Medicines with the same active substance, strength and form include: Atropine 1% w/v eye drops, solution, Atropine 1.0 % w/v eye drops, solution, Atropine Eye Drops BP 1.0% w/v Vistatropine Eye Drops 1.0% w/v. They are interchangeable only if your prescriber or pharmacist says so.
This leaflet reproduces the patient information leaflet approved for Minims Atropine Sulphate 1%, Eye drops solution, as published on the electronic medicines compendium (emc). The version printed inside your medicine’s packaging is the one that applies to you.
Whether a medicine is available over the counter or on prescription only depends on its licence. Check the leaflet, or ask your pharmacist — they can tell you straight away.
The text above reproduces the patient information leaflet approved for this medicine, restructured for easier reading.
As a topical mydriatic and cycloplegic.
Adults (including the elderly): One drop to be instilled into the eye, or as required.
Hypersensitivity to any component of the preparation. Due to the risk of precipitating an acute attack, do not use in cases of confirmed narrow-angle glaucoma or where latent narrow angle glaucoma is suspected. If in doubt it is recommended that an alternative preparation is used.
The protracted mydriasis which is difficult to reverse, may be a disadvantage. Systemic absorption may be reduced by compressing the lacrimal sac at the medial canthus for a minute during and following the instillation of the drops. (This blocks the passage of the drops via the naso-lacrimal duct to the wide absorptive area of the nasal and pharyngeal mucosa. It is especially advisable in children.)
None known.
The safety for use in pregnancy and lactation has not been established, therefore, use only when directed by a physician.
May cause transient blurring of vision on instillation. Warn patients not to drive or operate hazardous machinery until vision is clear.
Side effects rarely occur but include anticholinergic effects such as dry mouth and skin, flushing, increased body temperature, urinary symptoms, gastrointestinal symptoms and tachycardia. These effects are more likely to occur in infants and children.
Systemic reactions to topical atropine are unlikely at normal doses. Symptoms which can occur following an overdose, however, include anticholinergic effects (as listed in section 4.8 above), cardiovascular changes (tachycardia, atrial arrhythmias, atrio-ventricular dissociation) and central nervous system effects (confusion, ataxia, restlessness, hallucination, convulsions). Treatment is supportive.
Ask anything about Minims Atropine Sulphate 1%, Eye drops solution. The assistant answers only from this leaflet — if the leaflet does not cover it, it will say so. It does not give medical advice.
Answers come from the patient leaflet published on the electronic medicines compendium (emc). They are not medical advice. Ask a pharmacist or your GP if you are unsure. For urgent help call NHS 111, or 999 in an emergency.
We use essential cookies to make the site work. We would also like to set optional cookies to understand how the site is used, so we can improve it. We will not set optional cookies unless you accept. See our cookie policy and privacy policy.